Our Services
Medical Information
Helpful Resources
Published on: 4/13/2026
Restlessness on Abilify (aripiprazole) is a common side effect, often caused by dopamine-related changes that trigger akathisia or, less commonly, Restless Leg Syndrome. This typically appears shortly after starting Abilify or increasing your dose.
Do not stop the medication on your own. Contact your prescriber to discuss options such as a dose reduction, slower titration, or short-term treatments like propranolol, a benzodiazepine, an anticholinergic, or mirtazapine. Ask about checking your iron levels, and seek urgent care if you experience severe agitation or suicidal thoughts.
Because restlessness can stem from medication effects, an underlying condition, or another cause entirely, identifying the right next step matters. Take a free, instant, online symptom check to better understand what may be driving your symptoms and how to navigate your next steps with confidence.
Reviewed for medical accuracy: 06/22/2026
If you feel restless on Abilify, you are not imagining it — and you are not alone.
Abilify (aripiprazole) is a commonly prescribed medication used to treat conditions such as:
For many people, Abilify is highly effective and well tolerated. But one of its most commonly reported side effects is a feeling of inner restlessness. Some people describe it as:
This reaction has a medical explanation. Let's walk through what's happening in your brain — and what you can do about it safely.
Abilify works by affecting dopamine and serotonin, two key brain chemicals involved in mood, movement, and motivation.
Unlike many other psychiatric medications, Abilify is a partial dopamine agonist. This means it doesn't fully block dopamine — it adjusts dopamine activity up or down depending on what your brain is already doing.
That balancing effect helps many people. But in some cases, especially early in treatment or after a dose increase, the shift in dopamine signaling can trigger movement-related side effects.
The most common cause of restlessness on Abilify is a condition called:
Akathisia is a movement disorder characterized by:
It can start:
Akathisia is one of the most recognized side effects of Abilify and other antipsychotic medications. It is treatable — but it should not be ignored.
Sometimes people taking Abilify develop symptoms that sound more like Restless Leg Syndrome (RLS).
RLS typically includes:
While akathisia tends to feel like whole-body restlessness, RLS is usually focused in the legs and follows a circadian pattern (worse in the evening).
Abilify can sometimes worsen or trigger RLS, especially in people who are already prone to it.
If you're experiencing any unusual physical symptoms alongside your restlessness, using a free symptom checker can help you document and better understand what you're feeling before your next doctor's appointment.
Clinical studies show that akathisia occurs in approximately:
Risk factors include:
It is important to know that this reaction is dose-related and often manageable.
People describe it in different ways, including:
This sensation can be uncomfortable — and in severe cases, distressing. Rarely, untreated akathisia has been associated with worsening mood or agitation. That is why it's important to address it early.
However, most cases are mild to moderate and improve with medical adjustments.
If you feel restless on Abilify:
Suddenly stopping Abilify can lead to:
Instead, take structured next steps.
If you suspect Abilify is causing restlessness, here's what to do:
This is the most important step.
Explain:
Your doctor may:
Because Abilify-related restlessness is often dose-dependent, lowering the dose can significantly reduce symptoms while preserving benefits.
Never adjust dosing on your own.
Doctors sometimes prescribe short-term treatments such as:
These are prescribed based on individual risk factors and health history.
Low iron levels can worsen both akathisia and Restless Leg Syndrome.
Your doctor may check:
Correcting iron deficiency can sometimes reduce symptoms significantly.
Most restlessness on Abilify is uncomfortable but manageable.
However, you should seek immediate medical care if you experience:
If anything feels severe, sudden, or life-threatening, speak to a doctor immediately or seek emergency care.
While medical guidance is primary, supportive strategies may ease mild symptoms:
These do not treat akathisia itself but may reduce discomfort.
Often, yes.
Many people find that:
For others, the medication may not be the right fit — and that is okay. Mental health treatment is individualized.
The goal is always to balance:
If Abilify is helping your mental health significantly, your doctor may try adjusting rather than discontinuing it.
Feeling restless on Abilify is a known and medically recognized side effect. It usually stems from dopamine-related movement changes such as akathisia, and sometimes from Restless Leg Syndrome.
The key points:
Before your appointment, consider taking a few minutes to complete a free AI symptom assessment to help you clearly communicate all the symptoms you've been experiencing — this can make your conversation with your healthcare provider more productive and focused.
Most importantly, if symptoms feel severe, distressing, or involve thoughts of harming yourself, speak to a doctor immediately.
With the right medical guidance, restlessness on Abilify can usually be managed safely — and your treatment plan can be adjusted so you feel both mentally stable and physically comfortable.
(References)
* An, R., Yang, H., Chen, X., & Liu, Z. (2021). Aripiprazole-induced akathisia: A review of current research and therapeutic strategies. *Clinical Psychopharmacology and Neuroscience*.
* Miller, C. H., & O'Neal, M. C. (2020). Akathisia: A review of the pathophysiology and a guide to its treatment. *Annals of Clinical Psychiatry*.
* Chindaprasirt, S., & Srisurapanont, M. (2017). Management of antipsychotic-induced akathisia. *Neuropsychiatric Disease and Treatment*.
* Lim, Y. J., Kim, M. K., Jeong, G. M., & Kim, M. G. (2022). Prevalence and incidence of akathisia with second-generation antipsychotics: a meta-analysis. *CNS Drugs*.
* Lee, J., Seok, J. H., Jang, H., & Kim, Y. (2022). Risk factors for akathisia with second-generation antipsychotics: A meta-analysis. *Journal of Clinical Psychopharmacology*.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.